Vivus, FMC continue blame game before annual meeting
This article was originally published in Scrip
Executive Summary
Vivus disclosed statements from phone messages paid for by its largest shareholder First Manhattan Co (FMC), which the obesity drug developer says are false and misleading, in response to FMC's lawsuit claiming that the company did not have the authority to reschedule its annual shareholder meeting.